Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Personal Products
Personal Care
1,995 Cr
Moderate Risk
62.7
44.2
—
18.6
1,227.00
261.75
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Anondita Medicare Ltd (ANONDITA) is currently trading at 1,042.65 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Anondita Medicare Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Anondita Medicare Ltd has traded between a low of ₹261.75 and a high of ₹1,227.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Anondita Medicare Ltd has a market capitalization of approximately 1,995.04. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Anondita Medicare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 62.74 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,995.04 Cr, Anondita Medicare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Anondita Medicare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Anondita Medicare Ltd is 62.74. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Investor Presentation
Q2 FY26
Bearish
2
Neutral
9
Bullish
3
Bearish
6
Neutral
13
Bullish
27
Bearish
4
Neutral
4
Bullish
24
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1042.65 | 1,995 Cr | 62.74 | 18.58 | 0.00 | 21.21 | 22.40 | 19.45 | ||
177.00 | 277 Cr | 16.19 | 4.10 | 0.00 | 25.30 | 33.91 | 20.15 | ||
189.45 | 275 Cr | 85.65 | 11.80 | 0.27 | 13.72 | 18.56 | 13.61 | ||
234.50 | 234 Cr | 106.90 | 8.33 | 0.00 | 7.42 | 10.00 | 5.76 | ||
105.00 | 121 Cr | -36.64 | 2.29 | 0.00 | -3.41 | -3.28 | -13.20 | ||
172.00 | 117 Cr | 22.37 | 3.39 | 0.00 | 50.77 | 68.02 | 0.00 | ||
| Median: 6 Co. | — | 183.22 | 255 Cr | 42.55 | 6.21 | 0.00 | 17.47 | 20.48 | 9.68 |
Audited Financial Results
Board approved and filed audited standalone and consolidated financial results with auditors' report for the half‑year and year ended Mar 31, 2026 under Regulation 33; auditor issued an unmodified opinion; meeting held May 22, 2026.
Audited Financial Results
Board approved audited standalone and consolidated financial results for the half-year and year ended Mar 31, 2026; statutory auditors gave an unmodified opinion; declaration, deviation statement and RPT disclosures enclosed.
Integrated Financial Filing
Anondita Medicare submitted its audited consolidated integrated financial filing for the half‑year and year ended 31 Mar 2026 to the NSE; board approved results on 22 May 2026 with an unmodified audit opinion.
IPO proceeds reallocation
Anondita Medicare disclosed reallocations of IPO proceeds (IPO size Rs.6,949 lakhs); shareholders approved revisions on Feb 12, 2026, increasing allocation to General Corporate Purposes, removing 'unidentified acquisition' and deferring Rs.123.25 lakh to FY2026‑27.
Earnings Call
Anondita Medicare will hold an earnings conference call for H2 and FY2025-26 on May 27, 2026 at 4:00 PM; management (Chairman, MD, CFO) to participate with dial-in/register details provided.
